Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement
Journal of Psychopharmacology
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chungh, D.-S.
Right arrow Articles by Cho, S.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chungh, D.-S.
Right arrow Articles by Cho, S.-C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Neuroleptic malignant syndrome due to three atypical antipsychotics in a child

Dong-Seon Chungh

Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University Bundang Hospital, Seoul, Korea.

Boong-Nyun Kim

Division of Child and Adolescent Psychiatry, Department of psychiatry, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea.

Soo-Churl Cho

Division of Child and Adolescent Psychiatry, Department of psychiatry, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea., soochurl{at}snu.ac.kr

Neuroleptic Malignant Syndrome (NMS) is a rare, potentially fatal and idiosyncratic drug reaction. It is characterized by a sudden loss of body temperature control, renal and respiratory failure, muscle rigidity, loss of consciousness and impairment of autonomic nervous system. Although NMS was previously associated with the use of classical high-potency neuroleptics, cases have started to emerge with atypical neuroleptics. This article discusses the first case of NMS in a child, induced by the use of risperidone, olanzapine and quetiapine.

Key Words: neuroleptic malignant syndrome • risperidone • olanzapine • quetiapine

References

  • Aboraya A, Schumacher J, Abdalla E, Lepage J, McGhee M, Butcher D, Griffin H, Shahda M (2002) Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia . W V Med J 98: 63-65 [Medline] [Order article via Infotrieve]
  • Addonizio G, Susman V L (1987) ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome . J Clin Psychiatry 48: 102-105 [Medline] [Order article via Infotrieve]
  • Bajjoka I, Patel T, O’Sullivan T (1997) Risperidone-induced neuroleptic malignant syndrome: a case report . Ann Emerg Med 30(5): 698-700 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Beasley Jr, C MTollfson G D, Tran P D (1997) Efficacy of olanzapine: an overview of pivotal trials . J Clin Psychiatry 58 (Suppl. 10): 7-12
  • Bottlender R, Jager M, Hofschuster E, Dobmeier P, Moller H J (2002) Three episodes in one patient . Pharmacopsychiatry 35: 119-121 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bymaster F D, Colligaro D O, Flacone J F (1996) Radio receptor binding profile of the atypical antipsychotic olazapine . Neuropsychopharmacology 14: 87-96 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Caroff S N, Mann S C (1988) Neuroleptic malignant syndrome . Psychopharmacol Bull 24: 24-29
  • Caroff S N, Mann S C (1993) Neuroleptic malignant syndrome . Psychiatr Ann 77: 185-202
  • Casey D E (1996) Seroquel: preclinical and clinical findings of a new atypical antipsychotic . Exp Opin Invest Drugs 5: 939-957
  • David M, Remy C (1998) Case report: possible neuroleptic malignant syndrome associated with olanzapine . J Clin Psychopharmacol 18(6): 485-486 [Medline] [Order article via Infotrieve]
  • Donna W, Steven E S, Joseph P (2000) Nonextrapyramidal side effects of novel antipsychotics . Curr Opin Psychiatry 13(1): 45-50 [CrossRef]
  • Filice G A, McDougall B C, Ercan-Fang N (1998) Neuroleptic malignant syndrome associated with olanzapine . Ann Pharmacother 32: 158-1159
  • Gram L F (2002) Neuroleptic malignant syndrome in the treatment with the new, atypical antipsychotic agents, risperidone and olanzapine . Ugeskr Laeger 162: 1914-1915
  • Gratz S S, Simpson G M (1994) Neuroleptic malignant syndrome . Diagnosis, epidemiology and treatment. CNS Drugs 2: 429-439
  • Hasan S, Buckley P (1998) Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique . Am J Psychiatry 155: 1113-1116 [Abstract/Free Full Text]
  • Jibson M D, Tanson R (1998) New atypical antipsychotic medications . J Psychiat Res 32: 215-222 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kara gianis J L, Phillips L C, Hogan K P, Le Drew K K (1999) Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature . Ann Pharmacother 33: 623-630 [Abstract]
  • Kellam A M P (1987) The neuroleptic malignant syndrome, so-called: a survey of the world literature . Br J Psychiatry 150: 752-759 [Abstract/Free Full Text]
  • Keyser D L, Rodnitzky R L (1991) Neuroleptic malignant syndrome in Parkinson’s disease after withdrawal or duration of dopaminergic therapy . Arch Intern Med 14: 794-796 [CrossRef]
  • Knezevic W, Mastaglia F, Lefroy R (1984) Neuroleptic malignant syndrome . Med J Aust 140: 28-30 [Medline] [Order article via Infotrieve]
  • Latz S, McCracken J (1992) Neuroleptic malignant syndrome in children and adolescents: two case reports and a warning . J Child Adolesc Psychopharmacol 2: 123-129
  • Mills K C (1993) Serotonin toxicity: a comprehensive review of emergency medicine . Top Emerg Med 15: 54-73
  • Nopoulos D, Flaum M, Miller D D (1990) Atypical neuroleptic malignant syndrome with an atypical neuroleptic: clozapine induced neuroleptic malignant syndrome without rigidity . Ann Clin Psychiatr 2: 2251-2253
  • Pearlman C A (1986) Neuroleptic malignant syndrome . J Clin Psychopharmacol 6: 257-273 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Robb A S, Chang W, Lee H K, Cook M S (2002) Risperidone-induced neuroleptic malignant syndrome in an adolescent [Case study] . J Child Adolesc Psychopharmacol 10: 327-330
  • Saller C F, Salama A I (1993) Seroquel: biochemical profile of a potential atypical antipsychotic . Psychopharmacology 112: 285-292 [CrossRef][Medline] [Order article via Infotrieve]
  • Shalev A, Muniz H (1986) The neuroleptic malignant syndrome: agent and last interaction . Acta Psychiatry Scand 73: 337-347 [Web of Science][Medline] [Order article via Infotrieve]
  • Stanley A K, Hunter J (2000) Possible neuroleptic malignant syndrome with quetiapine . Br J Psychiatry 176: 497 [Free Full Text]
  • Steingard R, Khan A, Gonzalez A, Herzog D (1992) Neuroleptic malignant syndrome: review of experience with children and adolescents . J Child Adolesc Psychopharmacol 2: 183-198
  • Stewart F (2002) Pharmacology of atypical antipsychotics . Clin Neuropharmacol 25(3): 153-157 [Medline] [Order article via Infotrieve]
  • Tarshy D, Baldessarini R J, Tarazi F T (2002) Effects of newer antipsychotics on extrapyramidal function . CNS Drugs 16: 23-45 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tsai G, Crisostomo G, Rosenblatt M L, Stern T A (1995) Neuroleptic malignant syndrome associated with clozapine treatment . Ann Clin Psychiatry 7: 91-95 [Medline] [Order article via Infotrieve]
  • Vikram D, Jober R (2000) Quetiapine: a review of its safety in the management of schizophrenia . Drug Safety 23: 295-307 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Webster P, Wijeratne C (1994) Risperidone-induced neuroleptic malignant syndrome [letter] . Lancet 344: 1228-1229

Journal of Psychopharmacology, Vol. 19, No. 4, 422-425 (2005)
DOI: 10.1177/0269881105053310
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chungh, D.-S.
Right arrow Articles by Cho, S.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chungh, D.-S.
Right arrow Articles by Cho, S.-C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Advertisement